Association between hypoalbuminemia and toxicity by chemotherapy in elderly cancer patients

Authors

Keywords:

elderly, dependent elderly, frail elderly, neoplasms, drug - related side effects and adverse drug reactions.

Abstract

Introduction: The risk of mortality in elderly patients with cancer and the length of hospital stay are increased due to an albumin concentration lower than 3.5 g/dL.
Objective: To determine the association between hypoalbuminemia and chemotherapy toxicity in elderly oncological patients.
Methods: Cross-sectional study, conducted in 192 outpatients of Centro Médico Naval del Callao, Perú, males, older than 60 years old. Adverse effects to chemotherapy and associated factors were evaluated between 2013 and 2015. Crude and adjusted Cox regression models were created to determine the association between hypoalbuminemia and the development of chemotherapy toxicity.
Results: Association was found between hypoalbuminemia (HR= 1.03; 95% CI: 1.01-1.04), age (HR= 1.02; 95% CI: 1.01-1.04), malnutrition (HR= 1.1; 95% CI: 1.05-1.21), diabetes mellitus (HR= 1.05; 95% CI: 1.00-1.12), body fat percentage (HR= 0.97; 95% CI: 0.92 - 0.99) and chemotherapy toxicity.
Conclusions: In elderly oncology patients at Centro Médico Naval, a significant association is found between hypoalbuminemia and chemotherapy toxicity.

Downloads

Download data is not yet available.

References

1. Ruiz R, Romero E. Informe Técnico: Situación de la Población Adulta Mayor Abril-Mayo-Junio 2022. Boletín del Instituto Nacional de Estadística e Informática. 2022 [acceso: 16/07/2022]; 2:1-50. Disponible en: https://www.inei.gob.pe/media/MenuRecursivo/boletines/boletin-adulto-mayor-ene-mar-2022.pdf

2. Ramos W, De La Cruz-Vargas JA. Presentación del documento técnico "Análisis de la situación del cáncer en el Perú, 2018". Rev Fac Med Hum. 2020 [acceso: 10/07/2022]; 20(1):10-11. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S2308-05312020000100010

3. Suing-Ortega MJ, Tixi-Ramírez R. Hipoalbuminemia, un detractor en los gerontes oncológicos. J Cancerlol. 2019 [acceso: 10/07/2022]; 6:3-12. Disponible en: http://www.journalofcancerology.com/pdf/joc_19_6_1_3-12.pdf

4. Runzer-Colmenares FM, Urrunaga-Pastor D, Aguirre LG, Reategui- Rivera CM, Parodi JF, Taype Rondan A. Frailty and vulnerability as predictors of radiotoxicity in older adults: a longitudinal study in Peru. Med Clin. 2017 [acceso: 10/07/2022]; 149(8): 325-30. Disponible en: https://www.elsevier.es/es-revista-medicina-clinica-2-linkresolver-fragilidad-vulnerabilidad-como-predictores-radiotoxicidad-S0025775317301860

5. Runzer-Colmenares FM, Chambergo-Michilot D, Espinoza-Gutiérrez GA, Corcuera-Ciudad R, Patiño-Villena AF, Paima-Olivari R, et al. Diabetes mellitus tipo 2 y toxicidad por quimioterapia en adultos mayores con cáncer prostático. Rev. Habanera Cienc. Médi. 2019 [acceso: 10/07/2022];18(1):74-87. Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/2451

6. Alvis-Pena D, Calderón-Franco C. Descripción de factores de riesgo para mortalidad en adultos con enfermedad renal crónica en estadio 3 - 5. Acta Méd Perú. 2020 [acceso: 10/07/2022]; 37(2):163-8. Disponible en: http://www.scielo.org.pe/pdf/amp/v37n2/1728-5917-amp-37-02-163.pdf

7. Chambergo-Michilot D, Díaz-Villegas G, Merino-Taboada A, Runzer-Colmenares F. Relación entre malnutrición y valoración geriátrica en adultos mayores de 80 años. Nutr Clín Diet Hosp. 2020 [acceso: 10/07/2022]; 40(3):69-76. Disponible en: https://revista.nutricion.org/index.php/ncdh/article/view/59

8. Ortiz PJ, Varela LF, Tello T, Mas G. Características antropométricas asociadas a fragilidad en adultos mayores sin deterioro funcional que viven en comunidad. Rev Soc Peru Med Interna. 2017 [acceso: 10/07/2022]; 30(2):69-73. Disponible en: https://revistamedicinainterna.net/index.php/spmi/article/view/63

9. Guerrero-Villota JC, Benavides EY, Moreno-Correa SM. Efectos de la actividad física sobre el sistema inmune del adulto mayor. Salutem Scientia Spiritus. 2020 [acceso: 10/07/2022]; 6(1):74-80 Disponible en: https://redib.org/Record/oai_articulo2594560-efectos-de-la-actividad-f%C3%ADsica-sobre-el-sistema-inmune-del-adulto-mayor

10. Beracasa -Caro L, Pardo-Barón CA, Sánchez JO. Toxicidad relacionada con el tratamiento para el cáncer en adultos mayores: revisión de la literatura. Univ. Med. 2021 [acceso: 10/07/2022]; 62(1): 68-85. Disponible en: https://revistas.javeriana.edu.co/index.php/vnimedica/article/view/30777/25041

11. Castillo E, Montero G, García S. Asociación entre hipoalbuminemia e hipofosfatemia con desnutrición en pacientes con enfermedad renal crónica en hemodiálisis. Rev. Fac. Med. Hum. 2020 [acceso: 10/07/2022]; 20(3):381-7. Disponible en: https://inicib.urp.edu.pe/rfmh/vol20/iss3/7/

12. Arrieta O, Michel-Ortega RM, Villanueva-Rodríguez G, Serna-Thomé MG, Flores-Estrada D, Diaz-Romero C, et al. Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study. BMC Cancer. 2010 [acceso: 10/07/2022]; 10:50. Disponible en: https://bmccancer.biomedcentral.com/articles/10.1186/1471-2407-10-50

13. Dotan E, Tew WP, Mohile SG, Ma H, Kim H, Sun C-L, et al. Associations between nutritional factors and chemotherapy toxicity in older adults with solid tumors. Cancer. 2020 [acceso 10/07/2022]; 126(8):1708-16. Disponible en: https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.32718

14. Gérard S, Bréchemier D, Lefort A, Lozano S, Abellan van Kan G, Filleron T, et al. Body composition and anti-neoplastic treatment in adult and older subjects - A systematic review. J Nutr Health Aging. 2016 [acceso: 10/07/2022]; 20(8):878-88. Disponible en: https://pubmed.ncbi.nlm.nih.gov/27709238/

Downloads

Published

2022-12-15

How to Cite

1.
Prado V, Ramos G, Alor R, Cervantes L, Gutiérrez EL, Neyra-Rivera C, et al. Association between hypoalbuminemia and toxicity by chemotherapy in elderly cancer patients. Rev Cubana Med Milit [Internet]. 2022 Dec. 15 [cited 2025 Apr. 2];51(4):e02202290. Available from: https://revmedmilitar.sld.cu/index.php/mil/article/view/2290

Issue

Vol. 51 No. 4 (2022): October - December

Section

Research Article

License

Authors who have publications with this Journal accept the following terms:

  • The authors will retain their copyright and guarantee the Journal the right of first publication of their work, which will simultaneously be subject to the Creative Commons Attribution License. The content presented here can be shared, copied and redistributed in any medium or format; Can be adapted, remixed, transformed or created from the material, using the following terms: Attribution (giving appropriate credit to the work, providing a link to the license, and indicating if changes have been made); non-commercial (you cannot use the material for commercial purposes) and share-alike (if you remix, transform or create new material from this work, you can distribute your contribution as long as you use the same license as the original work).
  • The authors may adopt other non-exclusive license agreements for the distribution of the published version of the work (for example: depositing it in an institutional electronic archive or publishing it in a monographic volume) as long as the initial publication in this Journal is indicated.
  • Authors are allowed and recommended to disseminate their work through the Internet (e.g., in institutional electronic archives or on their website) before and during the submission process, which can produce interesting exchanges and increase citations. of the published work.